When the elephant in the room warrants discussion,  get on with it ...   We have been here before and Dissappointment ensues and yet another chunk of the company has been swallowed by Dart (eastern) 

   Resverlogix and Zenith NEED TO BREAK the Dart feeding trough...  the IP needs to be secured once and for all !   The science is ripe , epignetics is on fire ... I can only hope we partner with a first class investment house . 

  Saying that, (Pomade's) post was very welcome . The company needs to execute FOR BEST DEAL POSSIBLE ensuring trial completions and continued drug roll out ! 

   I truly hope Dart sits this round out , equity PP found at much higher levels , but history seems to repeat itself.

    SOMETHING exciting could be announced with Zenith April 3rd that could grandstand both companies epigenetic scaffolds of molecules . As a retail investor ,we could all benefit from enlarged investor pool increasing awareness and scientific knowledge...

Do the right thing by your shareholders Don .

Stock !